MRK
Merck & Co., Inc.
NYSE · USHealthcareDrug Manufacturers - General
$124.41-2.42%
Price as of Jul 20, 2026
MRK capital
Merck & Co., Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 1.07x
- Net debt / equity
- 0.95x
- Debt / assets
- 0.38x
- Debt / EBITDA
- 2.62x
- Net debt / EBITDA
- 2.33x
Liquidity & coverage
- Current ratio
- 1.30x
- Quick ratio
- 1.06x
- Cash ratio
- 0.21x
- Interest coverage
- 17.35x
- EBITDA / interest
- 18.00x
- Working capital
- $8.1B
Cash & dividend
- FCF / debt
- 0.29x
- Cash flow / debt
- 0.36x
- Dividend per share
- $3.36
- Dividend yield
- 2.7%
- Dividend growth 1y
- +5.1%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.